메뉴 건너뛰기




Volumn 33, Issue 10, 2010, Pages 2250-2253

Variation at the NFATC2 locus increases the risk of thiazolidinedione- induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RAMIPRIL; ROSIGLITAZONE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFATC2; UNCLASSIFIED DRUG;

EID: 79951685120     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc10-0452     Document Type: Article
Times cited : (34)

References (15)
  • 2
    • 19244365650 scopus 로고    scopus 로고
    • Thiazolidinediones
    • Yki-Järvinen H. Thiazolidinediones. N Engl J Med 2004;351:1106-1118
    • (2004) N Engl J Med , vol.351 , pp. 1106-1118
    • Yki-Järvinen, H.1
  • 3
    • 0033754530 scopus 로고    scopus 로고
    • Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: A 6-month randomized placebo-controlled dose-response study
    • The Pioglitazone 001 Study Group
    • Aronoff S, Rosenblatt S, Braithwaite S, Egan JW, Mathisen AL, Schneider RL. Pioglitazone hydrochloride monotherapy improves glycemic control in the treatment of patients with type 2 diabetes: a 6-month randomized placebo-controlled dose-response study. The Pioglitazone 001 Study Group. Diabetes Care 2000;23:1605-1611
    • (2000) Diabetes Care , vol.23 , pp. 1605-1611
    • Aronoff, S.1    Rosenblatt, S.2    Braithwaite, S.3    Egan, J.W.4    Mathisen, A.L.5    Schneider, R.L.6
  • 4
    • 33947134267 scopus 로고    scopus 로고
    • Thiazolidinediones and the risk of edema: A meta-analysis
    • DOI 10.1016/j.diabres.2006.09.010, PII S0168822706003949
    • Berlie HD, Kalus JS, Jaber LA. Thiazolidinediones and the risk of edema: a meta-analysis. Diabetes Res Clin Pract 2007;76:279-289 (Pubitemid 46400130)
    • (2007) Diabetes Research and Clinical Practice , vol.76 , Issue.2 , pp. 279-289
    • Berlie, H.D.1    Kalus, J.S.2    Jaber, L.A.3
  • 5
    • 34648832073 scopus 로고    scopus 로고
    • Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: A meta-analysis of randomised clinical trials
    • DOI 10.1016/S0140-6736(07)61514-1, PII S0140673607615141
    • Lago RM, Singh PP, Nesto RW. Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 diabetes given thiazolidinediones: a meta-analysis of randomised clinical trials. Lancet 2007;370:1129-1136 (Pubitemid 47464583)
    • (2007) Lancet , vol.370 , Issue.9593 , pp. 1129-1136
    • Lago, R.M.1    Singh, P.P.2    Nesto, R.W.3
  • 6
    • 0036852427 scopus 로고    scopus 로고
    • Peripheral edema
    • DOI 10.1016/S0002-9343(02)01322-0, PII S0002934302013220
    • Cho S, Atwood JE. Peripheral edema. Am J Med 2002;113:580-586 (Pubitemid 35379914)
    • (2002) American Journal of Medicine , vol.113 , Issue.7 , pp. 580-586
    • Cho, S.1    Atwood, J.E.2
  • 7
    • 33748748206 scopus 로고    scopus 로고
    • Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: A randomised controlled trial
    • DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators
    • DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators, Gerstein HC, Yusuf S, Bosch J, Pogue J, Sheridan P, Dinccag N, Hanefeld M, Hoogwerf B, Laakso M, Mohan V, Shaw J, Zinman B, Holman RR. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial. Lancet 2006;368:1096-1105
    • (2006) Lancet , vol.368 , pp. 1096-1105
    • Gerstein, H.C.1    Yusuf, S.2    Bosch, J.3    Pogue, J.4    Sheridan, P.5    Dinccag, N.6    Hanefeld, M.7    Hoogwerf, B.8    Laakso, M.9    Mohan, V.10    Shaw, J.11    Zinman, B.12    Holman, R.R.13
  • 10
    • 33748742987 scopus 로고    scopus 로고
    • The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist-induced edema in type 2 diabetic patients
    • DOI 10.1210/jc.2006-0590
    • Hansen L, Ekstrøm CT, Tabanera Y, Palacios R, Anant M, Wassermann K, Reinhardt RR. The Pro12Ala variant of the PPARG gene is a risk factor for peroxisome proliferator-activated receptor-gamma/alpha agonist- induced edema in type 2 diabetic patients. J Clin Endocrinol Metab 2006;91:3446-3450 (Pubitemid 44402117)
    • (2006) Journal of Clinical Endocrinology and Metabolism , vol.91 , Issue.9 , pp. 3446-3450
    • Hansen, L.1    Ekstrom, C.T.2    Tabanera, Y.P.R.3    Anant, M.4    Wassermann, K.5    Reinhardt, R.R.6
  • 11
    • 38449083331 scopus 로고    scopus 로고
    • Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar
    • DOI 10.1097/FPC.0b013e3282f1b2d7, PII 0121301120071200000007
    • Spraggs C, McCarthy A, McCarthy L, Hong G, Hughes A, Lin X, Sathe G, Smart D, Traini C, Van Horn S, Warren L, Mosteller M. Genetic variants in the epithelial sodium channel associate with oedema in type 2 diabetic patients receiving the peroxisome proliferator-activated receptor gamma agonist farglitazar. Pharmacogenet Genomics 2007;17:1065-1076 (Pubitemid 351339491)
    • (2007) Pharmacogenetics and Genomics , vol.17 , Issue.12 , pp. 1065-1076
    • Spraggs, C.1    McCarthy, A.2    McCarthy, L.3    Hong, G.4    Hughes, A.5    Lin, X.6    Sathe, G.7    Smart, D.8    Traini, C.9    Horn, S.V.10    Warren, L.11    Mosteller, M.12
  • 12
    • 0036234543 scopus 로고    scopus 로고
    • NFAT signaling: Choreographing the social lives of cells
    • DOI 10.1016/S0092-8674(02)00699-2
    • Crabtree GR, Olson EN. NFAT signaling: choreographing the social lives of cells. Cell 2002;109(Suppl.):S67-S79 (Pubitemid 34457853)
    • (2002) Cell , vol.109 , Issue.2 SUPPL. 1
    • Crabtree, G.R.1    Olson, E.N.2
  • 13
    • 53149117031 scopus 로고    scopus 로고
    • Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway
    • Bao Y, Li R, Jiang J, Cai B, Gao J, Le K, Zhang F, Chen S, Liu P. Activation of peroxisome proliferator-activated receptor gamma inhibits endothelin-1-induced cardiac hypertrophy via the calcineurin/NFAT signaling pathway. Mol Cell Biochem 2008;317:189-196
    • (2008) Mol Cell Biochem , vol.317 , pp. 189-196
    • Bao, Y.1    Li, R.2    Jiang, J.3    Cai, B.4    Gao, J.5    Le, K.6    Zhang, F.7    Chen, S.8    Liu, P.9


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.